Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04239235 · ClinicalTrials.gov registry record · NA
Integrating Support Persons Into Recovery
A NA study of Opioid Addiction, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 422
- Enrollment target
- 6
- Study locations
NCT04239235: Active NA study of Opioid Addiction, sponsored by Stanford University.
NCT04239235 is a NA study of Opioid Addiction that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 422 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04239235, a NA study of Opioid Addiction, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
- 6
- Study locations
Study Summary
INtegrated Support Persons Into Recovery (INSPIRE) is a 4-year research project that tests whether integrating a patient's support person into a patient's treatment with Buprenorphine/Naloxone can improve outcomes. The study will examine whether a counseling program called CRAFT for a support person, such as a family member, spouse or friend, can improve patient outcomes.
Primary Outcome
Percentage of patients who initiated OBOT who have at least 6 months of continuous treatment with buprenorphine with no more than a 7-day lapse between prescriptions
Conditions Studied
Interventions
- BEHAVIORAL CRAFT
Study Locations (6)
California
- Open Door Community Health Centers - Arcata
- Lifelong Medical Care - Berkeley
- Contra Costa Health Services - Concord
- Behavioral Health Services - Gardena
- Family Health Centers of San Diego - San Diego
- Venice Family Clinic - Venice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT04239235 still lists
NCT04239235 is an interventional study that assigns participants to a tested intervention. The registered 422 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Opioid Addiction appearing as the primary indexed condition, and to 1 intervention - of which CRAFT is the first listed.
NCT04239235 lists 6 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT04239235 about?
NCT04239235 is a clinical study titled "Integrating Support Persons Into Recovery". INtegrated Support Persons Into Recovery (INSPIRE) is a 4-year research project that tests whether integrating a patient's support person into a patient's treatment with Buprenorphine/Naloxone can improve outcomes. The study will examine whether a counseling program called CRAFT for a support person...
What is the current status of trial NCT04239235?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 422 participants. The study started on 2021-02-15. Estimated completion is 2026-01-31.
What conditions does trial NCT04239235 study?
This clinical trial studies the following conditions: Opioid Addiction.
What interventions are being tested in trial NCT04239235?
The interventions under investigation include: CRAFT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04239235?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04239235 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04239235's enrollment target sits among peer trials
422 238th of 2000 higher than 1,762 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
- NCT07298967 · 422 participants · NA
ORCHARDS-AIR Study
- NCT06935591 · 423 participants · NA
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI